UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 853

Sortiert nach

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

Lancet neurology, 2007-12, Vol.6 (12), p.1094-1105

2007

Volltextzugriff (PDF)

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

Journal of neurology, neurosurgery and psychiatry, 2012-11, Vol.83 (11), p.1125-1132

2012

Volltextzugriff (PDF)

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

Journal of neurology, neurosurgery and psychiatry, 2010-12, Vol.81 (12), p.1363-1368

2010

Volltextzugriff (PDF)

Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)

Neurology, 2003-01, Vol.60 (1), p.31

2003

Volltextzugriff (PDF)

Can the ABILHAND handle manual ability in MS?

Multiple sclerosis, 2013-05, Vol.19 (6), p.806-815

2013

Volltextzugriff (PDF)

Comparison of presentations to the emergency department during the COVID-19 pandemic (COPED-C)

Journal of public health (Oxford, England), 2021-12, Vol.43 (4), p.731-738

2021

Volltextzugriff (PDF)

Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis

Multiple sclerosis, 2011-02, Vol.17 (2), p.214-222

2011

Volltextzugriff (PDF)

High diversity and widespread occurrence of mitotic spore mats in ectomycorrhizal Pezizales

Molecular ecology, 2013-03, Vol.22 (6), p.1717-1732

2013

Volltextzugriff (PDF)

The problem with health measurement

Patient preference and adherence, 2011-01, Vol.5 (default), p.279-290

2011

Volltextzugriff (PDF)

Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)

Brain (London, England : 1878), 2006-01, Vol.129 (1), p.224-234

2006

Volltextzugriff (PDF)

Evidence-based measurement: which disability scale for neurologic rehabilitation?

Neurology, 2001-08, Vol.57 (4), p.639

2001

Volltextzugriff (PDF)

Effect sizes can be misleading: is it time to change the way we measure change?

Journal of neurology, neurosurgery and psychiatry, 2010-09, Vol.81 (9), p.1044-1048

2010

Volltextzugriff (PDF)

Quality of life measurement after stroke: Uses and abuses of the SF-36

Stroke (1970), 2002-05, Vol.33 (5), p.1348-1356

2002

Volltextzugriff (PDF)

Definitions, diagnosis, and decompression in spinal surgery: problems and solution

The spine journal, 2015-03, Vol.15 (3), p.S5-S8

2015

Volltextzugriff (PDF)

Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel Index and the Functional Independence Measure

Journal of neurology, neurosurgery and psychiatry, 1999-04, Vol.66 (4), p.480-484

1999

Volltextzugriff (PDF)

How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales

Journal of neurology, neurosurgery and psychiatry, 2005-11, Vol.76 (11), p.1539-1543

2005

Volltextzugriff (PDF)

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

Journal of neurology, neurosurgery and psychiatry, 2002-12, Vol.73 (6), p.701-704

2002

Volltextzugriff (PDF)

CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia

Neurology, 2006-12, Vol.67 (12), p.2230

2006

Volltextzugriff (PDF)

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles

Journal of neurology, neurosurgery and psychiatry, 2003-06, Vol.74 (6), p.710-714

2003

Volltextzugriff (PDF)

What sample sizes for reliability and validity studies in neurology?

Journal of neurology, 2012-12, Vol.259 (12), p.2681-2694

2012

Volltextzugriff (PDF)

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

BMC neurology, 2010-10, Vol.10 (1), p.88-88, Article 88

2010

Volltextzugriff (PDF)

Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58)

Neurology, 2004-11, Vol.63 (9), p.1629

2004

Volltextzugriff (PDF)

The five item Barthel index

Journal of neurology, neurosurgery and psychiatry, 2001-08, Vol.71 (2), p.225-230

2001

Volltextzugriff (PDF)

The impact of inpatient rehabilitation on progressive multiple sclerosis

Annals of neurology, 1997-08, Vol.42 (2), p.236-244

1997

Volltextzugriff (PDF)

Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?

Neurology, 1999-01, Vol.52 (1), p.50

1999

Volltextzugriff (PDF)

1 – 25 von 853

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(703)
Mit Volltextzugriff
(729)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(421)
Life Sciences & Biomedicine
(292)
Humans
(191)
Biological And Medical Sciences
(156)
Female
(118)
Male
(110)
Medical Sciences
(92)
Physical Sciences
(89)
Middle Aged
(79)
Adult
(78)
Technology
(77)
Social Sciences
(70)
Physics
(69)
Fundamental And Applied Biological Sciences. Psychology
(68)
Neurosciences & Neurology
(67)
Clinical Neurology
(66)
Aged
(58)
Animals
(51)
Neurology
(48)
Adolescent
(41)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)

Can the ABILHAND handle manual ability in MS?

Comparison of presentations to the emergency department during the COVID-19 pandemic (COPED-C)

Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis

High diversity and widespread occurrence of mitotic spore mats in ectomycorrhizal Pezizales

The problem with health measurement

Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)

Evidence-based measurement: which disability scale for neurologic rehabilitation?

Effect sizes can be misleading: is it time to change the way we measure change?

Quality of life measurement after stroke: Uses and abuses of the SF-36

Definitions, diagnosis, and decompression in spinal surgery: problems and solution

Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel Index and the Functional Independence Measure

How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles

What sample sizes for reliability and validity studies in neurology?

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58)

The five item Barthel index

The impact of inpatient rehabilitation on progressive multiple sclerosis

Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?

Suchergebnisse filtern